Bronte Jeffrey

1 month ago | onlinelibrary.wiley.com | Bronte Jeffrey |Mark Schifter |Emily Sullivan |Elizabeth Arena

1 Introduction Mucous membrane pemphigoid (MMP) is not a single disease; rather, it is a heterogeneous group of chronic, subepithelial, blistering diseases that primarily affect mucosal surfaces [1]. MMP was first differentiated from pemphigus and bullous pemphigoid by Walter Lever in 1953, who named the disease ‘benign MMP’. Despite this initial terminology, patients can have life-threatening or severely disabling, organ-threatening manifestations.